[1]
L. Luthvia, U. Harahap, and S. Nasution, “THE EFFECT OF ERYTHROPOIETIN DOSE PHASE OF CORRECTION AS DRUG-RELATED PROBLEMS TO TARGET LEVEL OF HEMOGLOBIN IN REGULAR HEMODIALYSIS PATIENTS”, Asian J Pharm Clin Res, vol. 11, no. 5, pp. 151–154, May 2018.